vs

Side-by-side financial comparison of Clorox (CLX) and Zebra Technologies (ZBRA). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($1.7B vs $1.5B, roughly 1.1× Zebra Technologies). Clorox runs the higher net margin — 9.4% vs 4.7%, a 4.6% gap on every dollar of revenue. On growth, Zebra Technologies posted the faster year-over-year revenue change (10.6% vs 0.3%). Over the past eight quarters, Zebra Technologies's revenue compounded faster (12.0% CAGR vs -8.3%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

Zebra Technologies Corporation (ZBR), commonly known as Zebra, is an American multinational technology conglomerate corporation specializing in smart data capture systems. Zebra is headquartered in Lincolnshire, Illinois outside of Chicago with 10,700 employees across 57 countries.

CLX vs ZBRA — Head-to-Head

Bigger by revenue
CLX
CLX
1.1× larger
CLX
$1.7B
$1.5B
ZBRA
Growing faster (revenue YoY)
ZBRA
ZBRA
+10.3% gap
ZBRA
10.6%
0.3%
CLX
Higher net margin
CLX
CLX
4.6% more per $
CLX
9.4%
4.7%
ZBRA
Faster 2-yr revenue CAGR
ZBRA
ZBRA
Annualised
ZBRA
12.0%
-8.3%
CLX

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
CLX
CLX
ZBRA
ZBRA
Revenue
$1.7B
$1.5B
Net Profit
$157.0M
$70.0M
Gross Margin
43.2%
47.3%
Operating Margin
9.4%
Net Margin
9.4%
4.7%
Revenue YoY
0.3%
10.6%
Net Profit YoY
-15.6%
-57.1%
EPS (diluted)
$1.29
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
ZBRA
ZBRA
Q4 25
$1.7B
$1.5B
Q3 25
$1.3B
Q2 25
$2.0B
$1.3B
Q1 25
$1.7B
$1.3B
Q4 24
$1.7B
$1.3B
Q3 24
$1.8B
$1.3B
Q2 24
$1.9B
$1.2B
Q1 24
$1.8B
$1.2B
Net Profit
CLX
CLX
ZBRA
ZBRA
Q4 25
$157.0M
$70.0M
Q3 25
$101.0M
Q2 25
$332.0M
$112.0M
Q1 25
$186.0M
$136.0M
Q4 24
$193.0M
$163.0M
Q3 24
$99.0M
$137.0M
Q2 24
$216.0M
$113.0M
Q1 24
$-51.0M
$115.0M
Gross Margin
CLX
CLX
ZBRA
ZBRA
Q4 25
43.2%
47.3%
Q3 25
48.0%
Q2 25
46.5%
47.6%
Q1 25
44.6%
49.3%
Q4 24
43.8%
48.6%
Q3 24
45.8%
48.8%
Q2 24
46.5%
48.4%
Q1 24
42.2%
47.9%
Operating Margin
CLX
CLX
ZBRA
ZBRA
Q4 25
9.4%
Q3 25
13.9%
Q2 25
20.6%
14.2%
Q1 25
15.2%
14.9%
Q4 24
14.1%
16.9%
Q3 24
10.0%
15.2%
Q2 24
14.5%
13.7%
Q1 24
-2.3%
13.5%
Net Margin
CLX
CLX
ZBRA
ZBRA
Q4 25
9.4%
4.7%
Q3 25
7.7%
Q2 25
16.7%
8.7%
Q1 25
11.2%
10.4%
Q4 24
11.4%
12.2%
Q3 24
5.6%
10.9%
Q2 24
11.4%
9.3%
Q1 24
-2.8%
9.8%
EPS (diluted)
CLX
CLX
ZBRA
ZBRA
Q4 25
$1.29
$1.40
Q3 25
$1.97
Q2 25
$2.68
$2.19
Q1 25
$1.50
$2.62
Q4 24
$1.54
$3.14
Q3 24
$0.80
$2.64
Q2 24
$1.74
$2.17
Q1 24
$-0.41
$2.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
ZBRA
ZBRA
Cash + ST InvestmentsLiquidity on hand
$227.0M
$125.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$-125.0M
$3.6B
Total Assets
$5.6B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
ZBRA
ZBRA
Q4 25
$227.0M
$125.0M
Q3 25
$1.1B
Q2 25
$167.0M
$872.0M
Q1 25
$226.0M
$879.0M
Q4 24
$290.0M
$901.0M
Q3 24
$278.0M
$676.0M
Q2 24
$202.0M
$411.0M
Q1 24
$219.0M
$127.0M
Total Debt
CLX
CLX
ZBRA
ZBRA
Q4 25
Q3 25
$2.2B
Q2 25
$2.5B
$2.2B
Q1 25
$2.2B
Q4 24
Q3 24
$2.2B
Q2 24
$2.5B
$2.2B
Q1 24
$2.1B
Stockholders' Equity
CLX
CLX
ZBRA
ZBRA
Q4 25
$-125.0M
$3.6B
Q3 25
$3.7B
Q2 25
$321.0M
$3.6B
Q1 25
$27.0M
$3.6B
Q4 24
$-41.0M
$3.6B
Q3 24
$60.0M
$3.4B
Q2 24
$328.0M
$3.3B
Q1 24
$91.0M
$3.2B
Total Assets
CLX
CLX
ZBRA
ZBRA
Q4 25
$5.6B
$8.5B
Q3 25
$8.1B
Q2 25
$5.6B
$7.9B
Q1 25
$5.5B
$7.9B
Q4 24
$5.6B
$8.0B
Q3 24
$5.5B
$7.7B
Q2 24
$5.8B
$7.5B
Q1 24
$5.8B
$7.3B
Debt / Equity
CLX
CLX
ZBRA
ZBRA
Q4 25
Q3 25
0.58×
Q2 25
7.74×
0.60×
Q1 25
0.60×
Q4 24
Q3 24
0.64×
Q2 24
7.56×
0.66×
Q1 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
ZBRA
ZBRA
Operating Cash FlowLast quarter
$357.0M
Free Cash FlowOCF − Capex
$327.0M
FCF MarginFCF / Revenue
22.2%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
5.10×
TTM Free Cash FlowTrailing 4 quarters
$831.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
ZBRA
ZBRA
Q4 25
$357.0M
Q3 25
$235.0M
Q2 25
$294.0M
$147.0M
Q1 25
$286.0M
$178.0M
Q4 24
$180.0M
$306.0M
Q3 24
$221.0M
$294.0M
Q2 24
$340.0M
$288.0M
Q1 24
$182.0M
$125.0M
Free Cash Flow
CLX
CLX
ZBRA
ZBRA
Q4 25
$327.0M
Q3 25
$216.0M
Q2 25
$219.0M
$130.0M
Q1 25
$233.0M
$158.0M
Q4 24
$127.0M
$288.0M
Q3 24
$182.0M
$277.0M
Q2 24
$259.0M
$278.0M
Q1 24
$127.0M
$111.0M
FCF Margin
CLX
CLX
ZBRA
ZBRA
Q4 25
22.2%
Q3 25
16.4%
Q2 25
11.0%
10.1%
Q1 25
14.0%
12.1%
Q4 24
7.5%
21.6%
Q3 24
10.3%
22.1%
Q2 24
13.6%
22.8%
Q1 24
7.0%
9.4%
Capex Intensity
CLX
CLX
ZBRA
ZBRA
Q4 25
2.0%
Q3 25
1.4%
Q2 25
3.8%
1.3%
Q1 25
3.2%
1.5%
Q4 24
3.1%
1.3%
Q3 24
2.2%
1.4%
Q2 24
4.3%
0.8%
Q1 24
3.0%
1.2%
Cash Conversion
CLX
CLX
ZBRA
ZBRA
Q4 25
5.10×
Q3 25
2.33×
Q2 25
0.89×
1.31×
Q1 25
1.54×
1.31×
Q4 24
0.93×
1.88×
Q3 24
2.23×
2.15×
Q2 24
1.57×
2.55×
Q1 24
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLX
CLX

Health And Wellness$643.0M38%
Household$419.0M25%
Lifestyle$321.0M19%
Other$290.0M17%

ZBRA
ZBRA

Tangible Products$1.2B83%
Service And Software$255.0M17%

Related Comparisons